Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank22
3Y CAGR-10.1%
5Y CAGR-10.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.1%/yr
vs -1.2%/yr prior
5Y CAGR
-10.8%/yr
Consistent
Acceleration
-8.9pp
Decelerating
Percentile
P22
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.86M | -25.2% |
| 2024 | $11.84M | -41.7% |
| 2023 | $20.30M | +66.4% |
| 2022 | $12.20M | -23.4% |
| 2021 | $15.93M | +1.6% |
| 2020 | $15.67M | +1.5% |
| 2019 | $15.44M | +20.3% |
| 2018 | $12.83M | +243.9% |
| 2017 | $3.73M | +118.3% |
| 2016 | $1.71M | - |